BioXcel Therapeutics $9.75M Class Action Settlement
Investors who purchased or otherwise acquired BioXcel Therapeutics Inc.
Approximately $1.52 per share before deductions from a $9,750,000 settlement fund
You'll go to: bioxcelsecuritiessettlement.com
Who may qualify
Investors who purchased or otherwise acquired BioXcel Therapeutics Inc. common stock between March 9, 2023, and June 28, 2023
This summary is based on available official settlement sources. The settlement administrator determines eligibility and payment approval.
New to the terms? Plain-English: claim deadline, proof of purchase, administrator, pro rata.
Important dates
- Claim deadline
- June 30, 2026
- Exclusion deadline
- August 5, 2026
- Objection deadline
- August 5, 2026
Proof requirements
Proof requirement is currently marked as Yes.
Review the official claim form before submitting any information.
How to file this claim
- Confirm you purchased or acquired BioXcel Therapeutics Inc. common stock (CUSIP 09075P204) between March 9, 2023, and June 28, 2023.
- Gather your brokerage records showing shares held as of the close of trading on March 8, 2023, all trade dates and prices through June 28, 2023, and shares held as of the close of trading on June 28, 2023.
- File your Proof of Claim and Release Form online at bioxcelsecuritiessettlement.com/file-a-claim/ or download, complete, and mail the PDF claim form to the settlement administrator before the claim deadline.
- If filing by mail, send to: Hills et al. v. BioXcel Therapeutics Inc., et al., c/o Strategic Claims Services, 600 N. Jackson St., Suite 205, P.O. Box 230, Media, PA 19063.
- If you are filing on behalf of another person (estate, trust, minor), include proof of your authority to act.
What the form asks
- — Your SSN (individuals) or EIN/TIN (entities) (Your tax documents or brokerage account records)
- — Number of BioXcel common shares you held at the end of trading the day before the class period began (Brokerage account statement for March 8, 2023)
- — Date of each buy or sell transaction during the class period (Broker confirmation slips or account statements)
- — Share quantity for each individual transaction (Broker confirmation slip for each trade)
- — Per-share price and total dollar value for each transaction (Broker confirmation slip for each trade)
- — Number of BioXcel common shares you held at end of trading on the last day of the class period (Brokerage account statement for June 28, 2023)
Documents you'll need
Watch out for
- All joint purchasers must sign the claim form — a missing co-owner signature can void the claim.
- Executors, administrators, guardians, conservators, and trustees must attach proof of authority when filing on behalf of others.
- Shares bought and sold entirely before June 29, 2023, have a recognized loss of zero and will generate no payout.
- Class members whose calculated payment falls below a minimum threshold will not receive a payout.
- Payout is pro rata and depends on the total number of valid claims submitted — actual recovery may be higher or lower than the estimated average.
We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.
How do I file a claim for this settlement?
File directly with Strategic Claims Services via the official claim form before June 30, 2026.
- Confirm you are within the eligible group described in the official notice — the settlement administrator determines eligibility.
- Gather any documents the official form asks for — this settlement marks proof as Yes.
- Open the official claim form or settlement website run by Strategic Claims Services.
- Submit accurate information through the official settlement administrator or government source before June 30, 2026.
- Save your confirmation number if one is provided, then watch the payment status for distribution updates.
New to settlement claims? How to file safely →
Worried it might be fake? Run the 60-second legitimacy check →
How we verified this record
- Claim deadline the official settlement website · Jun 19, 2026
- Payout details the official settlement website · Jun 19, 2026
- Eligibility the official settlement website · Jun 19, 2026
- Proof requirement the official settlement website · Jun 19, 2026
- Administrator the official settlement website · Jun 19, 2026
- Official claim link the official settlement website · Jun 19, 2026
- Payment status the official settlement website · Jun 19, 2026
- Court case queued for re-check
Every published record clears our source-verification bar; remaining fields are checked one by one on our weekly re-verification pass.
Checked fields are matched against a named official source and re-checked on a schedule. We show the authority and the date, never our internal evidence link.
-
Claim deadline
June 30, 2026
Verified Jun 19, 2026 · against the official settlement website
-
Eligibility summary
Investors who purchased or otherwise acquired BioXcel Therapeutics Inc. common stock between March 9, 2023, and June 28, 2023
Verified Jun 19, 2026 · against the official settlement website
-
Proof requirement
Yes
Verified Jun 19, 2026 · against the official settlement website
-
Payment status
Claim period open
Verified Jun 19, 2026 · against the official settlement website
-
Estimated payout
Approximately $1.52 per share before deductions from a $9,750,000 settlement fund
Verified Jun 19, 2026 · against the official settlement website
-
Administrator
Strategic Claims Services
Verified Jun 19, 2026 · against the official settlement website
Show all 7 more verified fields
-
Official claim URL
bioxcelsecuritiessettlement.com
Verified Jun 19, 2026 · against the official settlement website
-
Objection deadline
August 5, 2026
Verified Jun 19, 2026 · against the official settlement website
-
Opt-out deadline
August 5, 2026
Verified Jun 19, 2026 · against the official settlement website
-
Class period start
March 9, 2023
Verified Jun 19, 2026 · against the official settlement website
-
Class period end
June 28, 2023
Verified Jun 19, 2026 · against the official settlement website
-
Court
United States District Court for the District of Connecticut
Verified Jun 19, 2026 · against the official settlement website
-
Case name
Hills et al. v. BioXcel Therapeutics, Inc., et al.
Verified Jun 19, 2026 · against the official settlement website
Hills et al. v. BioXcel Therapeutics, Inc., et al.
Common questions
Is the BioXcel Therapeutics $9.75M Class Action settlement legitimate?
Yes — the BioXcel Therapeutics $9.75M Class Action settlement is a real claims process that SettleSignal tracks from its official source. It is administered by Strategic Claims Services. File only through the official settlement website (bioxcelsecuritiessettlement.com); a genuine settlement administrator never charges a fee to file. SettleSignal last checked this record against the official source on June 19, 2026. Always confirm the current details on the official site before filing.
Who may qualify for this settlement?
Investors who purchased or otherwise acquired BioXcel Therapeutics Inc. common stock between March 9, 2023, and June 28, 2023
What is the claim deadline?
The claim deadline is June 30, 2026. Confirm the current deadline on the official settlement source before filing.
Do I need proof to claim?
Proof requirement: Yes. The settlement administrator determines what documentation, if any, is required.
What is the current payment status?
Current payment status: Claim period open. Payments are issued by the administrator after the court process concludes.
When will BioXcel Therapeutics $9.75M Class Action Settlement pay out?
Current payment status: Claim period open. Class-action payouts typically begin only after final approval and any appeals. See our payout timeline guide.
Where is the official BioXcel Therapeutics $9.75M Class Action Settlement claim form?
The official claim form is hosted by the settlement administrator, Strategic Claims Services. Use the 'Open official claim form' button on this page — never pay a fee to file.
Where to act
When you are ready, you open the official claim form yourself. SettleSignal does not file claims or determine eligibility.
Listed on the official settlement website (Strategic Claims Services).
Disclaimer
This service summarizes publicly available settlement information and links to official settlement sources. We are not a law firm, do not provide legal advice, do not submit claims on your behalf, and do not determine eligibility or payout approval. Only file a claim if the information you provide is accurate.
Change log
- June 19, 2026 — Settlement published after verification.
- June 19, 2026 — Verified field details updated from an official source.